Lantheus Medical Imaging
Focus: Lantheus Medical Imaging is a specialized biotechnology company focused on small molecule radiopharmaceuticals and contrast agents for diagnostic imaging across oncology, cardiovascular, and nephrology. As a public company headquartered in Massachusetts, they maintain a niche but established market position in medical imaging.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Lantheus Medical Imaging
AI assessmentNot HiringNo open roles listed right now. Follow Lantheus Medical Imaging to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
7 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak11.0yr
Flagship ultrasound contrast agent with extended patent protection (LOE 2037) serving as core revenue driver for cardiovascular imaging.
Help build intelligence for Lantheus Medical Imaging
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.